Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Biochemical Society Transactions
|
January 21, 2012
ERK5 and its role in tumour development
Pamela A Lochhead, Rebecca Gilley, Simon J Cook
Cellular Signalling
|
March 3, 2009
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos
Rebecca Gilley, H Nikki March, Simon J Cook
Biochemical Society Transactions
|
July 19, 2013
Adaptation to chronic mTOR inhibition in cancer and in aging
Rebecca Gilley, Kathryn Balmanno, Claire L Cope, et al.
The FEBS Journal
|
May 27, 2017
Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling
Simon J Cook, Kate Stuart, Rebecca Gilley, et al.
Cellular Signalling
|
October 21, 2006
The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1
Claire J Chalmers, Rebecca Gilley, Helen N March, et al.
Cellular Signalling
|
September 20, 2011
CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL
Rebecca Gilley, Pamela A Lochhead, Kathryn Balmanno, et al.
The Biochemical Journal
|
February 21, 2024
Reporter cell lines to screen for inhibitors or regulators of the KRAS-RAF-MEK1/2-ERK1/2 pathway
Laura Weatherdon, Kate Stuart, Megan Cassidy, et al.
The EMBO Journal
|
May 26, 2007
ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL
Katherine E Ewings, Kathryn Hadfield-Moorhouse, Ceri M Wiggins, et al.
Journal of Cell Science
|
December 24, 2013
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Claire L Cope, Rebecca Gilley, Kathryn Balmanno, et al.
Molecular Cell
|
November 18, 2019
An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis
Richard I Odle, Simon A Walker, David Oxley, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Biochemical Society Transactions
|
January 21, 2012
ERK5 and its role in tumour development
Pamela A Lochhead, Rebecca Gilley, Simon J Cook
Cellular Signalling
|
March 3, 2009
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos
Rebecca Gilley, H Nikki March, Simon J Cook
Biochemical Society Transactions
|
July 19, 2013
Adaptation to chronic mTOR inhibition in cancer and in aging
Rebecca Gilley, Kathryn Balmanno, Claire L Cope, et al.
The FEBS Journal
|
May 27, 2017
Control of cell death and mitochondrial fission by ERK1/2 MAP kinase signalling
Simon J Cook, Kate Stuart, Rebecca Gilley, et al.
Cellular Signalling
|
October 21, 2006
The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1
Claire J Chalmers, Rebecca Gilley, Helen N March, et al.
Cellular Signalling
|
September 20, 2011
CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL
Rebecca Gilley, Pamela A Lochhead, Kathryn Balmanno, et al.
The Biochemical Journal
|
February 21, 2024
Reporter cell lines to screen for inhibitors or regulators of the KRAS-RAF-MEK1/2-ERK1/2 pathway
Laura Weatherdon, Kate Stuart, Megan Cassidy, et al.
The EMBO Journal
|
May 26, 2007
ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL
Katherine E Ewings, Kathryn Hadfield-Moorhouse, Ceri M Wiggins, et al.
Journal of Cell Science
|
December 24, 2013
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Claire L Cope, Rebecca Gilley, Kathryn Balmanno, et al.
Molecular Cell
|
November 18, 2019
An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis
Richard I Odle, Simon A Walker, David Oxley, et al.
Page
of 2